Galmed制药公司宣布调整其财务安排,一方面将增加80万美元的现金支付,另一方面,针对一笔200万美元的盈利支付条款进行了重组,新的支付结构计划从2027年第三季度开始生效。
Galmed制药公司宣布调整其财务安排,一方面将增加80万美元的现金支付,另一方面,针对一笔200万美元的盈利支付条款进行了重组,新的支付结构计划从2027年第三季度开始生效。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.